Related Experiment Videos
[The ocular manifestations in systemic lupus erythematosus]
1Policlinica Griviţa, Bucureşti.
Oftalmologia (Bucharest, Romania : 1990)
|April 1, 1996
Summary
Systemic lupus erythematosus (SLE) primarily causes retinal microangiopathy, leading to occlusive events. While severe retinal ischemia cases exist, better SLE management has reduced occlusive phenomena, though papilledema remains significant.
Area of Science:
- Ophthalmology
- Rheumatology
- Systemic Lupus Erythematosus
Context:
- Retinal microangiopathy is a key feature of Systemic Lupus Erythematosus (SLE).
- Occlusive vascular events, including retinal ischemia, are known complications.
- Recent trends suggest a decline in severe occlusive phenomena due to improved SLE management.
Purpose:
- To review the spectrum of ocular manifestations in SLE.
- To highlight the significance of retinal microangiopathy and papilledema in SLE patients.
- To emphasize the importance of ophthalmic evaluations in suspected or confirmed SLE cases.
Summary:
- Retinal involvement in SLE is characterized by microangiopathy, historically leading to occlusive events.
- Despite documented cases of severe retinal ischemia, improved SLE therapy and monitoring have decreased the incidence of these occlusive phenomena.
- Papilledema occurs with notable frequency and can be unilateral or asymptomatic, underscoring the need for vigilant ophthalmic assessment.
Impact:
- Ophthalmic examinations are crucial for early detection and management of SLE-related eye conditions.
- This review underscores the importance of ophthalmology in diagnosing and managing patients with SLE-like syndromes or seronegative SLE.
- Understanding these ocular manifestations aids in comprehensive patient care and disease monitoring.